It was revealed from a comprehensive analysis of TREM1 expression data obtained from The Cancer Genome Atlas Program (TCGA) and GTEx that TREM1 was highly expressed in the majority of cancers, including glioblastoma multiforme (GBM) and lower grade gliomas (LGG) (Figure 1A). This evidence concerns the gene TREM1 and central nervous system cancer.